Literature DB >> 9075303

Is a child's risk of early onset schizophrenia increased in the highest social class?

T Mäkikyrö1, M Isohanni, J Moring, H Oja, H Hakko, P Jones, P Rantakallio.   

Abstract

In a sample from the unselected, general population Northern Finland 1966 Birth Cohort, 11017 individuals alive at the age of 16 years were studied until the age of 27. The cumulative incidence of early onset schizophrenia until 23 years was higher (1.14%; 9/792) among young persons from the highest social class or class I (determined according to father's occupation) than among children from lower social classes (0.47%; 48/10225), the difference being statistically significant (p < 0.05). The incidence of schizophrenia in the highest social class was higher than expected among girls, firstborns, children of young mothers under 30 and urban residents (p < 0.05) compared with lower social classes. When cases from the highest and other social classes were compared, there was no clear difference in background factors or clinical course. Four alcoholics, one of them also schizophrenic, were found among nine social class I fathers. The results suggest that in some families in Northern Finland, a father's professional advancement, often linked to mental disorder, may be one determinant of an increased risk of schizophrenia in the child.

Entities:  

Mesh:

Year:  1997        PMID: 9075303     DOI: 10.1016/s0920-9964(96)00119-3

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  24 in total

Review 1.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

2.  Social disadvantage and schizophrenia. A combined neighbourhood and individual-level analysis.

Authors:  Marjan Drukker; Lydia Krabbendam; Ger Driessen; Jim van Os
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-06-02       Impact factor: 4.328

3.  Is initiation of smoking associated with the prodromal phase of schizophrenia?

Authors:  Kaisa Riala; Helinä Hakko; Matti Isohanni; Anneli Pouta; Pirkko Räsänen
Journal:  J Psychiatry Neurosci       Date:  2005-01       Impact factor: 6.186

4.  The public mental health significance of research on socio-economic factors in schizophrenia and major depression.

Authors:  Benedetto Saraceno; Itzhak Levav; Robert Kohn
Journal:  World Psychiatry       Date:  2005-10       Impact factor: 49.548

5.  Socioeconomic status at birth is associated with risk of schizophrenia: population-based multilevel study.

Authors:  Shirli Werner; Dolores Malaspina; Jonathan Rabinowitz
Journal:  Schizophr Bull       Date:  2007-04-18       Impact factor: 9.306

Review 6.  The antecedents of schizophrenia: a review of birth cohort studies.

Authors:  Joy Welham; Matti Isohanni; Peter Jones; John McGrath
Journal:  Schizophr Bull       Date:  2008-07-24       Impact factor: 9.306

7.  First psychiatric hospitalizations in the US military: the National Collaborative Study of Early Psychosis and Suicide (NCSEPS).

Authors:  Richard Herrell; Ioline D Henter; Ramin Mojtabai; John J Bartko; Diane Venable; Ezra Susser; Kathleen R Merikangas; Richard J Wyatt
Journal:  Psychol Med       Date:  2006-07-31       Impact factor: 7.723

8.  The relationship between risk of hospitalization for schizophrenia, SES, and cognitive functioning.

Authors:  Shira Goldberg; Eyal Fruchter; Michael Davidson; Abraham Reichenberg; Rinat Yoffe; Mark Weiser
Journal:  Schizophr Bull       Date:  2011-05-20       Impact factor: 9.306

9.  A classification of sociomedical health indicators: perspectives for health administrators and health planners.

Authors:  A E Siegmann
Journal:  Int J Health Serv       Date:  1976       Impact factor: 1.663

Review 10.  Developmental precursors of psychosis.

Authors:  Matti Isohanni; Irene Isohanni; Hannu Koponen; Johanna Koskinen; Pekka Laine; Erika Lauronen; Jouko Miettunen; Pirjo Mäki; Kaisa Riala; Sami Räsänen; Kaisa Saari; Pekka Tienari; Juha Veijola; Graham Murray
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.